Redx Pharma Plc (REDX)

London
67.00
0.00(0.00%)
  • Volume:
    15
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    67.00 - 67.00

REDX Overview

Prev. Close
67
Day's Range
67-67
Revenue
17.34M
Open
67
52 wk Range
52-129.9
EPS
-0.07
Volume
15
Market Cap
218.41M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
12,413
P/E Ratio
-
Beta
0.64
1-Year Change
8.94%
Shares Outstanding
333,353,161
Next Earnings Date
-
What is your sentiment on Redx Pharma Plc?
or
Market is currently closed. Voting is open during market hours.

Redx Pharma Plc Company Profile

Redx Pharma Plc Company Profile

Employees
40

Redx Pharma plc is a United Kingdom-based company, which is focused on the discovery and development of novel medicines for the treatment of cancer and fibrotic diseases. The Company’s product pipeline includes RXC004 and ROC007. Its lead product candidate RXC004, which is a potent, selective, oral small molecule inhibitor of the enzyme, Porcupine, a key activator of Wnt ligands in the Wnt signalling pathway. RXC004 is in Phase I study in combination with nivolumab (OPDIVO- Bristol Myers Squibb, an anti-PD-1 antibody). The RXC007 is a selective small molecule inhibitor that targets Rho Associated Coiled-Coil Containing Protein Kinase 2 (ROCK2) which sits at a nodal point in a cell signaling pathway. RXC007 is used for the treatment of fibrotic diseases.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuySellBuy
Technical IndicatorsStrong BuyBuyStrong BuyStrong BuySell
SummaryStrong BuyStrong BuyStrong BuyNeutralNeutral